Strategic Partnerships Olive Diagnostics has actively pursued collaborations with national utilities and health organizations, including Mekorot, suggesting a strong openness to B2B collaborations that leverage their passive urine analysis tech for water quality monitoring and public health initiatives.

Hospital & Enterprise With a focus on real-time health alerts and early disease detection via a passive sensor, there are clear opportunities to target hospitals, clinics, elder care facilities, and telehealth providers seeking non-invasive continuous monitoring solutions.

Chronic Disease Market The device monitors biomarkers relevant to diabetes, kidney function, infections, and pregnancy, indicating potential to integrate with care pathways for chronic disease management, pregnancy care programs, and preventive wellness services.

Industrial & Public Health Partnerships in water and environmental monitoring suggest cross-sell opportunities to utilities and public health agencies for early warning systems, combining urine-based health data with water quality insights.

Scale & Commercialization Recent financing and product expansions such as Olive KG and Olive WatchOS demonstrate a growth trajectory; sales teams can capitalize on expanding product line and geographic reach by targeting health tech distributors, system integrators, and certification-driven markets.